Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentary.
Arthur SillahScott S TykodiEvan T HallJohn A ThompsonNathaniel F WatsonSylvia M LeeShailender BhatiaJoshua VeatchJeannie WarnerUlrike PetersRachel C MalenAllison SilvermanAmanda I PhippsPublished in: Future oncology (London, England) (2021)
Lifestyle factors could plausibly modulate the host immune system, the tumor microenvironment and, hence, immune checkpoint inhibitor (ICI) response. As such, these factors should be considered in ICI studies.